Screening compound: LIASMTYFSIFYFK-MHZLTWQESA-N

Screening compound: LIASMTYFSIFYFK-MHZLTWQESA-N
Screening compound: LIASMTYFSIFYFK-MHZLTWQESA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
LIASMTYFSIFYFK-MHZLTWQESA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4369-0026

Molecular Formula

C31H32N2O5 (C31 H32 N2 O5)

Compound Name

2-(4-methoxyphenyl)-2-oxoethyl 2-[(4-tert-butylphenyl)formamido]-3-(1H-indol-3-yl)propanoate

IUPAC name

2-(4-methoxyphenyl)-2-oxoethyl 2-[(4-tert-butylphenyl)formamido]-3-(1H-indol-3-yl)propanoate

SMILES

CC(C)(C)c(cc1)ccc1C(NC(Cc1c[nH]c2c1cccc2)C(OCC(c(cc1)ccc1OC)=O)=O)=O

InChI

InChI=1S/C31H32N2O5/c1-31(2,3)23-13-9-21(10-14-23)29(35)33-27(17-22-18-32-26-8-6-5-7-25(22)26)30(36)38-19-28(34)20-11-15-24(37-4)16-12-20/h5-16,18,27,32H,17,19H2,1-4H3,(H,33,35)/t27-/m0/s1

InChI Key

LIASMTYFSIFYFK-MHZLTWQESA-N

MDL Number (MFCD)

MFCD06663588

LIASMTYFSIFYFK-MHZLTWQESA-N in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

3D-Biodiversity Library (27607 compounds)

CORONAVIRUS Library (20774 compounds)

Human Receptors Annotated Library (5376 compounds)

PLpro Library (6343 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • 3D
  • Mimetics
Mechanism of action:
  • PPI modulators
Targets:
  • Proteases
  • Phosphatases

References: we are preparing a list of scientific research reports with LIASMTYFSIFYFK-MHZLTWQESA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound LIASMTYFSIFYFK-MHZLTWQESA-N?
Check Price and Availability of LIASMTYFSIFYFK-MHZLTWQESA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of LIASMTYFSIFYFK-MHZLTWQESA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for LIASMTYFSIFYFK-MHZLTWQESA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for LIASMTYFSIFYFK-MHZLTWQESA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of LIASMTYFSIFYFK-MHZLTWQESA-N available by request